HEL •
Healthcare •
Biotechnology •
Quote as of 06/26/2026 18:29
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeHEL
Market Capitalization73.59 mln
Float24.54 mln
Earnings Date05/19/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.11
Caution advised
1-Year Forecast
2.12
Transformational upside
Relative Strength
49
/ 100
In line with market
Debt / Equity
0.16
Very low leverage
ROE
-34.51
Deeply negative
Business Description
Nanoform Finland Oyj helps pharmaceutical and biotech companies improve how drugs are made by breaking drug particles down to the nanoscale level. Founded in 2008 and based in Helsinki, the company offers a range of services including specialized particle engineering technologies, formulation development, and analytical support. It also provides STARMAP, a digital tool that helps clients identify which drug molecules are best suited for its nanoforming process.
